Organisation paid for research Program year 2025 Source: CMS Open Payments

Western Institutional Review

Neither a doctor nor a teaching hospital

Research payments

$308,422

211 payments

Through program year 2025, Western Institutional Review is reported as receiving $308,422 in research payments, across 211 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$95,204	11
2023	Research	$6,195	8
2022	Research	$28,432	24
2021	Research	$55,532	50
2020	Research	$33,062	35
2019	Research	$89,997	83

Breakdown

Who paid Research payments · program years 2019–2025

Amgen Inc. $95,204 11 payments
Pulmonx Corporation $63,158 57 payments
Encore Medical, LP $51,316 41 payments
Djo, LLC $45,487 46 payments
Nevro Corp. $43,484 46 payments
Allergan Inc. $6,307 8 payments
AstraZeneca Pharmaceuticals LP $2,894 1 payment
AbbVie, Inc. $572 1 payment

Studies the money was for Research payments · program years 2019–2025

A Phase 1, Randomized, Double-blind, Placebo-controlled, Integrated Single Ascending Dose, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 691 in Healthy and Mild-to-moderate Asthma Participants $58,348 1 payment
Zephyr Valve Registry $55,657 50 payments
Chronic Peripheral Polyneuropathy Randomized Trial $23,518 25 payments
PS-706 - e-plus $18,726 15 payments
Post Market Observational Study $12,410 12 payments
Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty: A randomized, controlled trial $10,671 9 payments
Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig in Combination with ARDT Switch vs Docetaxel or ARDT Switch in Subjects with Chemotherapy-nave mCRPC $10,546 1 payment
Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty A randomized, controlled trial $9,845 9 payments
Lung Function Improvement after Bronchoscopic Lung Volume Reduction with Pulmonx Endobronchial Valves used in Treatment of Emphysema $7,501 7 payments
Judd PS-607 ROC $7,071 7 payments

What the money was spent on Research payments · program years 2019–2025

Other $42,788 38 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.